Keywords: Prostate, MR Value
Motivation: Prostate cancer (PCa) screening via prostate-specific antigen (PSA) testing is prone to over- and under-diagnosis. MRI shows promise but is hindered by long scan times, cost and limited availability.
Goal(s): To evaluate the imaging findings of an abbreviated biparametric (bp)MRI protocol for PCa screening.
Approach: The ReIMAGINE study screened men aged 50-75 with PSA testing and an abbreviated MRI. Positive MRI or raised PSA density ≥0.12 ng/mL² (PSAd) triggered follow-up with multiparametric MRI +/- biopsy.
Results: One in six men had a positive screening MRI. The screening MRI detected more clinically significant cancers than PSAd alone, with a positive predictive value of 59%.
Impact: Prostate MRI may have value in prostate cancer screening independently of prostate-specific antigen testing, offering an opportunity for early cancer detection. Future research is needed to optimise the screening approach to make MRI a more feasible, cost-effective screening tool.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords